PHI with Thrombosis of the intracranial venous system
How does this condition affect your private health insurance?
Thrombose des intrakraniellen Venensystems, or Cerebral Venous Sinus Thrombosis (CVST), is a rare form of stroke caused by a blood clot obstructing the venous sinuses that drain blood from the brain. This can lead to increased intracranial pressure, brain swelling, and potentially hemorrhagic infarction. Symptoms are highly variable, often including severe headaches, seizures, focal neurological deficits, and altered consciousness. Risk factors include prothrombotic states (e.g., genetic clotting disorders, oral contraceptive use, pregnancy, puerperium), infections, and inflammatory conditions. Early diagnosis with imaging (MRV/CTV) and prompt anticoagulation are crucial for optimal outcomes and minimizing severe complications.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Acute symptoms and initial hospital care typically last several days to 2-3 weeks, with symptom resolution potentially extending over weeks to months.
Duration of Illness (Lifetime)
Typically a one-time event. However, some patients may require long-term anticoagulation, and residual symptoms like chronic headaches or epilepsy can persist indefinitely. Recurrence is possible in a small percentage of cases.
Cost of Treatment (Initial)
Estimated costs for acute care, including hospitalization, imaging, and medication, range from $15,000 to $60,000, depending on severity and length of stay.
Cost of Treatment (Lifetime)
Additional costs for follow-up appointments, potential rehabilitation, long-term medication (e.g., anticoagulants, anti-epileptic drugs), and management of chronic symptoms could add $5,000 to $30,000 over many years.
Mortality Rate
With modern treatment, the probability of death is approximately 3-10%.
Risk of Secondary Damages
The probability of experiencing secondary damage, such as chronic headaches, epilepsy, cognitive impairment, or focal neurological deficits, is around 30-50%.
Probability of Full Recovery
Approximately 70-85% of patients achieve complete or near-complete recovery without significant long-term disability.
Underlying Disease Risk
A significant majority, approximately 80-90%, have identifiable underlying prothrombotic risk factors or associated conditions at the time of diagnosis.